Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial (Q83209550)
Jump to navigation
Jump to search
scientific article published on 21 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial |
scientific article published on 21 January 2009 |
Statements
Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial (English)
Elmar Stickeler
Dirk Watermann
Annette Geibel
Martha Földi
Annette Hasenburg
Gerald Gitsch
21 January 2009